Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sensipar
Pharma
Amgen sales slide as copies dig into Sensipar, Neulasta
Amgen is working to grow sales for new meds, but in the second quarter, costly losses of exclusivity for Sensipar and Neulasta hurt the drugmaker.
Eric Sagonowsky
Jul 30, 2019 4:36pm
DOJ: Astellas, Amgen fork over $125M to settle kickback probes
Apr 25, 2019 1:55pm
Amgen, Teva strike Sensipar patent deal after brief launch
Jan 3, 2019 10:33am
Mylan biosim ready to challenge Amgen blockbuster Neulasta
Jun 5, 2018 11:10am
Patent fights jump in 2017, led by Eli Lilly, Pfizer, Sanofi and more
May 4, 2018 11:50am
Amgen, Sandoz trial over Enbrel patents delayed, filings suggest
Apr 2, 2018 12:25pm
